Praxis Precision Medicines, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
PRAX Nasdaq 2834 praxismedicines.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Praxis Precision Medicines, Inc.

Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress - Jan 12th, 2026 6:00 am
Needham Analyst Keeps a Buy Rating on Praxis Precision Medicines, Inc. (PRAX) - Jan 10th, 2026 11:07 pm
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 9th, 2026 2:01 pm
High Growth Tech Stocks In The US For January 2026 - Jan 9th, 2026 4:38 am
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments - Jan 8th, 2026 2:45 pm
Praxis Precision Medicines (PRAX) Valuation Check After A Strong 90 Day Share Price Run - Jan 7th, 2026 11:12 am
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering - Jan 6th, 2026 9:15 pm
Praxis Precision Medicines, Inc. Announces Proposed Public Offering - Jan 6th, 2026 2:03 pm
Praxis Precision granted Breakthrough Therapy designation for Ulixacaltamide - Dec 30th, 2025 6:05 am
Why Praxis Precision Medicines Stock Popped Today - Dec 29th, 2025 5:39 pm
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading - Dec 29th, 2025 1:50 pm
Praxis Precision Heading for 'Exciting' 2026, Truist Says - Dec 29th, 2025 1:23 pm
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor - Dec 29th, 2025 6:00 am
Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More - Dec 29th, 2025 5:52 am
Has Praxis Precision Medicines Rally Gone Too Far or Is the Market Still Missing Something - Dec 15th, 2025 6:06 pm
Praxis tees up another approval filing; Geron turns to layoffs - Dec 12th, 2025 3:18 am
Praxis Precision Medicines Announces Plans to File an NDA for Relutrigine in SCN2A and SCN8A Developmental and Epileptic Encephalopathies in Early 2026 - Dec 11th, 2025 6:00 am
TD Cowen Lifts Praxis Precision Medicines Inc. (PRAX) Price Target amid NDA for Essential Tremor Treatment - Dec 11th, 2025 5:44 am
Praxis Precision Medicines Announces Alignment with FDA on Simplified and Accelerated Registrational Pathway for Elsunersen in Early Onset SCN2A Developmental and Epileptic Encephalopathy - Dec 9th, 2025 2:01 pm
High Growth Tech Stocks to Watch in US December 2025 - Dec 9th, 2025 4:38 am